Error: Could not add to watchlist. X
+ Watchlist

BB Adamant Global Medtech und

ADAGMEG:SW
140.95
CHF
0.96
0.68%
As of 11/17/2017
Fund Type
Open-End Fund
52Wk Range
109.34 - 142.72
1 Yr Return
26.15%
YTD Return
26.38%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Previous Close
141.91
52Wk Range
109.34 - 142.72
1 Yr Return
25.95%
YTD Return
26.38%
Fund Type
Open-End Fund
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
Global
NAV (on 11/17/2017)
140.95
Total Assets (m CHF) (on 11/17/2017)
101.429
Inception Date
02/19/2015
Last Dividend (on 01/18/2017)
-
Dividend Indicated Gross Yield
-
Fund Managers
OLIVER KUBLI / STEFAN BLUM
Front Load Fee
-
Back Load Fee
-
Redemption Fee
-
12b-1 Fee
-
Current Mgmt Fee
1.15%
Expense Ratio
1.08%

Top Fund Holdings

Name Position Value % of Fund
70.00 k 11.59 m 12.74
102.50 k 8.31 m 9.13
55.00 k 5.18 m 5.69
73.00 k 5.15 m 5.66
103.00 k 4.65 m 5.11
74.50 k 4.11 m 4.51
24.00 k 3.61 m 3.97
49.50 k 3.50 m 3.85
24.60 k 3.17 m 3.49
60.00 k 3.06 m 3.36
Profile
BB Adamant Global Medtech und Services is an open-ended investment company incorporated in Switzerland. The Fund's aim is to generate long-term capital growth through active management by investing in companies within the medicinal sector. The Fund's portfolio will be concentarted to around 30 to 50 stocks which fully meet Adamant's strict selection criteria.
Address
Swisscanto Fondsleitung AG
Bahnhofstrasse 9
8001 Zuerich
Switzerland
Phone
Tel: +41 58 344 49 00